Publications found:
54,468
Sort by:
World Molecular Diagnostics Market 2017: Emerging Technologies and Strategic Profiles of Leading Suppliers
US$ 3,500.00
... report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection ... strategic assessments of current and emerging suppliers of molecular diagnosticsproducts, including their sales, product portfolios, marketing tactics, technological know- how, new products ...
July 2017
180 pages
Spain Enteric Diseases Market Analysis and Emerging Opportunities 2021
US$ 2,200.00
... 322- page report from VPGMarketResearch.com presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter ... key suppliers and potential market entrants developing innovativetechnologies and products Analyzes emerging opportunities, alternative market penetration strategies,market entry barriers/risks ...
July 2017
322 pages
French Enteric Diseases Market Analysis and Emerging Opportunities 2021
US$ 2,200.00
... new 322- page report from VPGMarketResearch.com presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter ... key suppliers and potential market entrants developing innovativetechnologies and products Analyzes emerging opportunities, alternative market penetration strategies,market entry barriers/risks ...
July 2017
322 pages
Asia Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast
US$ 1,200.00
... market for breast cancer mammogram screening. Renub Research study titled “Asia Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast” analyzes the Asia market For Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market ...
July 2017
-
Colorectal Cancer [2016]: Bulletin #3
US$ 1,045.00
... presents key opinion leader (KOL) views on recent developments in the Colorectal Cancer (CRC) market. Topics covered include: Bristol-Myers Squibb (BMS ... mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC); Roche announcing data from two Phase I studies evaluating ...
July 2017
-
Medical Affairs Reputations: Type 2 Diabetes Mellitus (US)
US$ 6,175.00
Find out what the leading medical affairs teams in type 2 diabetes are doing right Medical affairs teams for several leading T2DM treatments in the US ... your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (US). Comparing 11 major melanoma treatments from ...
June 2017
-
Prostate Cancer [2016]: Bulletin #3
US$ 1,045.00
... key opinion leader (KOL) insights on the latest events happening in prostate cancer.Topics covered include expert opinions on; the results of the Phase ... (cfDNA) can be used to assess treatment response in men with advanced prostate cancer who are administered with AstraZeneca's PARP inhibitor Lynparza (olaparib ...
June 2017
-
The Chinese Market for Cancer Intervention
US$ 5,500.00
The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a ... compound annual growth rate (CAGR) of 13.8% through 2022. Cancer treatment ...
June 2017
130 pages
Europe Nucleic Acid Testing/NAT Market 2021: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 17,730.00
... , UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies ... range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend ...
June 2017
1273 pages
U.K. Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... -page market segmentation analysis of the UK NAT market. Major issues pertaining to the UK NAT laboratory practice, as well as key economic, ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1122 pages
U.S. Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 8,550.00
... -page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1157 pages
France Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... 1,125-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1125 pages
Germany Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... 1,125-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1125 pages
Japan Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 7,650.00
... 126-page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1126 pages
Spain Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... 1,117-page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1117 pages
Italy Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... 1,117-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1117 pages
US Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 5,850.00
... 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in US hospitals. Current instrumentation technologies and feature comparison ...
June 2017
567 pages
UK Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in UK hospitals. Current instrumentation technologies and feature comparison ...
June 2017
527 pages
French Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in French hospital laboratories. Instrumentation technologies and feature ...
June 2017
897 pages
German Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in German hospital laboratories. Instrumentation technologies and feature ...
June 2017
897 pages
Italian Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Italian hospital laboratories. Instrumentation technologies and feature ...
June 2017
887 pages
Japanese Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 5,220.00
... , 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Japanese hospital laboratories. Instrumentation technologies and feature ...
June 2017
891 pages
Spanish Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Spanish hospital laboratories. Instrumentation technologies and feature ...
June 2017
880 pages
French Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in French hospitals. Current instrumentation technologies and feature comparison ...
June 2017
533 pages
German Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in German hospitals. Current instrumentation technologies and feature comparison ...
June 2017
530 pages
Italian Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Italian hospitals. Current instrumentation technologies and feature comparison ...
June 2017
525 pages
Japanese Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,365.00
... , 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Japanese hospitals. Current instrumentation technologies and feature comparison ...
June 2017
537 pages